Literature DB >> 7333332

New aspects in the metabolism of alinidine in man.

D Arndts, H J Forster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7333332     DOI： 10.1007/BF03189531

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  6 in total

1.  Clinical pharmacology and pharmacokinetics of clonidine.

Authors:  C T Dollery; D S Davies; G H Draffan; H J Dargie; C R Dean; J L Reid; R A Clare; S Murray
Journal:  Clin Pharmacol Ther       Date:  1976-01       Impact factor: 6.875

2.  Determination of clonidine in human plasma by glass capillary gas chromatography with electron-capture detection.

Authors:  P O Edlund
Journal:  J Chromatogr       Date:  1980-01-04

3.  Proof of the linearity of the pharmacokinetics of alinidine in man.

Authors:  D Arndts; H Warnkross; K L Rominger; H Justus
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Development of a RIA for clonidine and its comparison with the reference methods.

Authors:  D Arndts; H Stähle; H J Förster
Journal:  J Pharmacol Methods       Date:  1981-12

5.  Development and quality control of a highly sensitive radioimmunoassay for alinidine.

Authors:  D Arndts; H Stähle
Journal:  J Pharmacol Methods       Date:  1981-09

6.  Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.

Authors:  D Arndts; G Leb; H J Förster
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441
  6 in total
  4 in total

1.  Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.

Authors:  M Boucher; E Chapuy; M A Lefebvre; A Mignot; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

2.  [Treatment of hyperkinetic heart syndrome with alinidine and propranolol].

Authors:  R Schräder; G Degoutrie; H Landgraf; M Kaltenbach
Journal:  Klin Wochenschr       Date:  1987-01-15

3.  Blood level, distribution, metabolite pattern and excretion of [14C]alinidine in mice and rats.

Authors:  W D Bechtel; I Richter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jul-Sep       Impact factor: 2.441

4.  An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.

Authors:  D W Harron; D Arndts; M Finch; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.